Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure

Published:2019-05-13 Issue:7 Volume:23 Page:4779-4794
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Goltsman Ilia¹,Khoury Emad E.¹,Aronson Doron²,Nativ Omri¹,Feuerstein Giora Z.²³,Winaver Joseph¹,Abassi Zaid¹⁴^ORCID

Affiliation:

1. Department of Physiology Bruce Rappaport Faculty of Medicine Technion‐IIT Haifa Israel

2. Department of Cardiology Rambam Health Care Campus Haifa Israel

3. FARMACON LLC, Translational Medicine Company Bryn Mawr Pennsylvania

4. Department of Laboratory Medicine Rambam Health Care Campus Haifa Israel

Funder

Israeli Science Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14366

Reference50 articles.

1. Epidemiology of Heart Failure

2. Research Advances in Heart Failure

3. Diabetes Mellitus and Heart Failure: Epidemiology, Mechanisms, and Pharmacotherapy

4. Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug

5. Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents;Pharmaceuticals;2023-10-12

2. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor;Pharmacology & Therapeutics;2021-05

3. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2;European Journal of Pharmacology;2020-11

4. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS;The Journal of Clinical Endocrinology & Metabolism;2020-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3